Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Neovascular Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Large-scale testing (Phase 3)Study completedNCT00531024
What this trial is testing

Systemic Avastin Therapy in Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 30
Early research (Phase 1)Study completedNCT07484074
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Who this might be right for
Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration
Ollin Biosciences, Inc. 164
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Testing effectiveness (Phase 2)Study completedNCT01494805
What this trial is testing

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more
Lions Eye Institute, Perth, Western Australia 40
Not applicableStudy completedNCT03744806
What this trial is testing

Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Lublin 48
Large-scale testing (Phase 3)Looking for participantsNCT07007065
What this trial is testing

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
AbbVie 561
Testing effectiveness (Phase 2)Study completedNCT03216538
What this trial is testing

Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Feramda 20
Large-scale testing (Phase 3)Study completedNCT05587062
What this trial is testing

Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration
Cinnagen 168
Large-scale testing (Phase 3)Study completedNCT03150589
What this trial is testing

Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Samsung Bioepis Co., Ltd. 705
Large-scale testing (Phase 3)Study completedNCT04423718
What this trial is testing

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

Who this might be right for
Neovascular Age-Related Macular Degeneration
Bayer 1,011
Not applicableStudy completedNCT01644513
What this trial is testing

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients

Who this might be right for
Age Related Macular Degeneration
Sequenom, Inc. 196
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Large-scale testing (Phase 3)Study completedNCT03386474
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 151
Large-scale testing (Phase 3)Study completedNCT05604989
What this trial is testing

Associations Between the Oral and Intestinal Microbiome and Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Seoul National University Bundang Hospital 45
Large-scale testing (Phase 3)Study completedNCT00100009
What this trial is testing

Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 30
Post-approval studies (Phase 4)UnknownNCT02681783
What this trial is testing

PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept

Who this might be right for
Central Serous ChorioretinopathyAge Related Macular DegenerationIdiopathic Poplypoidal Choroidal Vasculopathy
Sunnybrook Health Sciences Centre 90
Large-scale testing (Phase 3)WithdrawnNCT04697953
What this trial is testing

Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals
Not applicableUnknownNCT01608113
What this trial is testing

Long-term Follow-up of Subfoveal Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Vienna 70
Post-approval studies (Phase 4)Study completedNCT01453920
What this trial is testing

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 44
Next Page